Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.240
-0.070 (-2.11%)
Aug 8, 2025, 4:00 PM - Market closed
Accolade Market Cap
Kyverna Therapeutics has a market cap or net worth of $140.03 million as of August 8, 2025. Its market cap has decreased by -63.59% in one year.
Market Cap
140.03M
Enterprise Value
-95.68M
1-Year Change
-63.59%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $140.03M, a decrease of -84.41%. That is a compound annual growth rate of -71.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 140.03M | -13.27% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |